Zobrazeno 1 - 4
of 4
pro vyhledávání: '"José Antonio Escario García-Trevijano"'
Autor:
Sergio Sifontes-Rodríguez, Lianet Monzote-Fidalgo, Nilo Castañedo-Cancio, Ana Margarita Montalvo-Álvarez, Yamilé López-Hernández, Niurka Mollineda Diogo, Juan Francisco Infante-Bourzac, Oliver Pérez-Martín, Alfredo Meneses-Marcel, José Antonio Escario García-Trevijano, Miguel Ángel Cabrera-Pérez
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 110, Iss 2, Pp 166-173 (2015)
Despite recent advances in the treatment of some forms of leishmaniasis, the available drugs are still far from ideal due to inefficacy, parasite resistance, toxicity and cost. The wide-spectrum antimicrobial activity of 2-nitrovinylfuran compounds h
Externí odkaz:
https://doaj.org/article/2ff87b6086bc49b2a1d74e21942ab074
Autor:
Alexandra Ibáñez Escribano, Alfredo Meneses Marcel, Yanetsy Machado Tugores, Juan José Nogal Ruiz, Vicente J Arán Redó, José Antonio Escario García-Trevijano, Alicia Gómez Barrio
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 107, Iss 5, Pp 637-643 (2012)
A fluorimetric microassay that uses a redox dye to determine the viability of the flagellate Trichomonas vaginalis has been optimised to provide a more sensitive method to evaluate potential trichomonacidal compounds. Resazurin has been used in recen
Externí odkaz:
https://doaj.org/article/3d54a80d7ae7461d8654683bf4d01c96
Autor:
Sergio Sifontes Rodríguez, Niurka Mollineda-Diogo, Lianet Monzote-Fidalgo, Alma Reyna Escalona-Montaño, José Antonio Escario García-Trevijano, María Magdalena Aguirre-García, Alfredo Irenaldo Meneses-Marcel
Leishmaniasis is a neglected disease with high prevalence and incidence in tropical and subtropical areas. Existing drugs are limited due to cost, toxicity, declining efficacy and unavailability in endemic places. Drug repurposing has established as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a82b65b68bf5881ab6d14df054e96ab
https://doi.org/10.21203/rs.3.rs-2711791/v1
https://doi.org/10.21203/rs.3.rs-2711791/v1
Autor:
Sergio Sifontes Rodríguez, Claudia Sissely Chaviano-Montes de Oca, Lianet Monzote-Fidalgo, Susana Meneses-Gómez, Niurka Mollineda-Diogo, José Antonio Escario García-Trevijano
Publikováno v:
Ars Pharmaceutica (Internet) v.63 n.3 2022
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Introduction: Amphotericin B is an effective drug for the treatment of the different clinical forms of leishmaniasis. However, there are reports of its ineffectiveness in animals experimentally infected with Leishmania spp. That is why, the objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff25b0758cd605891784f9a7451e560c
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2340-98942022000300005
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2340-98942022000300005